Lumosa Therapeutics is pleased to introduce our new CBO, Mr. Christopher Aleong

Chris has over 25 years of strategic cross-functional and cross-divisional experience in mature and emerging markets involving both regional and multi-country roles in the pharmaceutical and biotechnology industries. He is responsible for leading the BD team, sharing his vast knowledge in negotiation, deal-making, corporate strategy, and driving Lumosa`s global presence and business acceleration as the Company expands into new territories and markets.